Recent Posts
- Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference 2026 in London
- Tiziana KOL Call Highlights Consistency Between Positive Phase 2a INFORM-MS Topline Results and Longer-Term Clinical Benefits Observed in Expanded Access Program for Patients with Non-Active Secondary Progressive Multiple Sclerosis Treated with Intranasal Foralumab
- Tiziana Life Sciences to Present at BIO-Europe 2026 and Host KOL Webcast
- Tiziana to Host Investor Call with Key Opinion Leaders to Discuss Positive Phase 2a INFORM-MS Topline Results
- Tiziana Announces Positive Topline Results from Phase 2a INFORM-MS Trial of Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis
Recent Comments
No comments to show.